While a recent study reported that also the abrogation of TGF-β signalling in CD11c+ cells leads to the development of autoimmune disease [40], this seems unlikely in our system since recombination in CD4+ CD11c+ cells was very rare. This evidence concerns the gene ITGAX and autoimmune disease.